The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Aug. 24, 2021

Filed:

May. 07, 2019
Applicant:

The University of Tokyo, Tokyo, JP;

Inventors:

Hirotaka Matsuo, Saitama, JP;

Nariyoshi Shinomiya, Saitama, JP;

Tappei Takada, Tokyo, JP;

Assignee:

Other;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C12Q 1/68 (2018.01); C12P 19/34 (2006.01); C12Q 1/6883 (2018.01); A61K 38/00 (2006.01); C07K 14/47 (2006.01); G01N 33/68 (2006.01); A61K 38/17 (2006.01); A61K 38/44 (2006.01); A61K 38/45 (2006.01); A61K 38/53 (2006.01); C12N 9/00 (2006.01); A61K 48/00 (2006.01);
U.S. Cl.
CPC ...
C12Q 1/6883 (2013.01); A61K 38/00 (2013.01); A61K 38/177 (2013.01); A61K 38/1709 (2013.01); A61K 38/44 (2013.01); A61K 38/45 (2013.01); A61K 38/53 (2013.01); C07K 14/47 (2013.01); G01N 33/6893 (2013.01); A61K 48/00 (2013.01); C12N 9/00 (2013.01); C12Q 2600/156 (2013.01); C12Y 102/01003 (2013.01); C12Y 207/11025 (2013.01); C12Y 603/04 (2013.01); G01N 2800/107 (2013.01);
Abstract

To specify a molecule associated with the onset of gout so as to provide a method for evaluating a diathesis of uric acid-related diseases and a diathesis of inflammation-related diseases, an evaluation kit for carrying out the method, an inspection object, and a drug, on the basis of the molecule specified above, for contributing to the early treatment and prevention of the uric acid-related diseases and inflammation-related diseases. The molecule includes any one protein and cDNA of CNIH2-PACS1, ALDH2, MYL2-CUX2, GCKR, MAP3K11, NPT4, ABCG2, HIST1H2BF/HIST1H4E, HIST1H2BE/HIST1H4D and FAM35A, or proteins of combination thereof with GLUT9, NPT1, URAT1, or NXRN2, and is capable of selectively inducing gout. A molecule includes protein and cDNA of an ABCG2 variant and is capable of selectively and ATP-dependently decreasing urate excretion.


Find Patent Forward Citations

Loading…